In silico designing of domain B selective gyrase inhibitors for effective treatment of resistant tuberculosis.
In silico designing of domain B selective gyrase inhibitors for effective treatment of resistant tuberculosis. Tuberculosis (Edinb). 2018 09; 112:83-88.